Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of Decompensated Chronic Heart Failure.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* A written informed consent must be obtained for hospitalized male or female patients over 18 years old of age.~* The eligible patients must be diagnosed with worsening heart failure as evidenced by dyspnea at rest, poor ejection fraction and have been treated with IV diuretics.~* It is allowable for the patients to be treated with IV inotropes and vasodilators.~Exclusion Criteria:~The following criteria would exclude the patient from study:~* invasive cardiac procedure (e.g. cardiac surgery, LVAD, cardioversion, cardiac re-synchronization),~* rhythm disorders (e.g. earlier Torsades de Pointes, increased heart rate),~* severe ventricular outflow obstruction,~* angina,~* hypotension,~* uncorrected hypokalemia,~* CNS (e.g. stroke, TIA),~* respiratory (e.g. COPD, intubated patients, oral,~* intravenous or intramuscular steroids),~* renal insufficiency (e.g. increased serum creatinine, dialysis),~* hepatic impairment (e.g. significant increase in liver enzymes),~* decompensation from active infection and acute bleeding (e.g. severe anemia).~* Female patients of child bearing potential must have a negative pregnancy test and use adequate contraceptive precautions.~* Also excluded is the use of amrinone and milrinone prior to randomization, a history of hypersensitivity to levosimendan or any of the excipients and previous participation in a clinical trial with any experimental treatment within the last 30 days.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).